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SUMMARY
Objective: We analyzed the evolution in the Health Related Quality of Life
(HRQOL) during the first year following renal transplant. Methods: Prospective and
longitudinal study carried out with 28 patients who received a primary cadaveric
renal transplant. The tests applied were a structured interview and SF-36, Euroqol-
5D (EQ-5D) Health Questionnaires and End-Stage Renal Disease Symptom Chec-
klist-Transplantation Module (ESRD-SCL). Results: With the course of time, the renal
patients improve in four areas: physical («physical functioning» and «cardiac and
renal malfunction»), psychological («vitality» and «mental health»), execution of
daily tasks («limitations in role in order to physical problems» and «daily tasks») and
subjective perception of own state of health («current health»). Conclusions: The
HRQOL in renal transplant patients improves with the course of time.
Key words: Renal transplantation. Health related quality of life. Pre and post-
transplantation phases.
EVOLUCIÓN DE LA CALIDAD DE VIDA RELACIONADA CON LA SALUD
EN LOS TRASPLANTADOS RENALES
RESUMEN
Objetivo: Hemos analizado la evolución de la Calidad de Vida Relacionada con la
Salud (CVRS) en el primer año del trasplante renal. Métodos: Estudio prospectivo y lon-
gitudinal realizado con 28 pacientes que recibieron un primer trasplante renal de cadá-
ver. Fueron evaluados en cuatro fases diferentes: en el momento de su inclusión en lista
de espera para trasplante y a los tres, seis y doce meses de haber recibido el injerto. Em-
pleamos una entrevista estructurada y los siguientes instrumentos: Cuestionario de
Salud SF-36, Cuestionario de Salud Euroqol-5D (EQ-5D) y End-Stage Renal Disease
Symptom Checklist-Transplantation Module (ESRD-SCL). Resultados: A medida que
transcurre el tiempo, los trasplantados renales mejoran en cuatro áreas: física («funcio-
namiento físico» y «disfunción cardíaca y renal»), psicológica («vitalidad» y «salud
mental»), realización de las tareas cotidianas («limitaciones en el rol por problemas físi-
cos» y «actividades cotidianas») y percepción subjetiva de su estado de salud («salud
actual»). Conclusiones: La CVRS en los trasplantados renales mejora a largo plazo.
Palabras clave: Trasplante renal. Calidad de vida relacionada con la salud. Fases
pre y post-trasplante.
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INTRODUCTION
Health-related quality of life (HRQOL) is a multidi-
mensional construct including three basic domains
(physical functioning, psychological functioning, and
social functioning) that may be affected by disease
and/or treatment.1-3 Assessing the evolution of this
construct in renal transplant patients is necessary,
among other reasons, to determine the effectiveness
of the medical intervention, to improve the clinical
decisions, to manage the physical, functional, psy-
chological, and social aspects of the patient’s course,
to understand the quality of life of the main caregi-
vers, and to plan for psychosocial and rehabilitation
interventions.4-6
Most of the studies on this topic conclude that all
renal transplant patients present an HRQOL similar to
that of the general population, and better than that of
patients on chronic hemodialysis.7, 8 Regarding evolu-
tion of HRQOL after renal transplant, the investiga-
tions establishing different comparison periods after
transplantation are of great interest. For instance,
there are studies concluding that patients with more
than 10 years after transplantation have poorer qua-
lity of life as compared with those with less than 5
years, likely due to older age and the side effects of
immunosuppressive medication.9 Other investiga-
tions conclude that HRQOL decreases between the
third and sixth months, with less intensity in trans-
planted patients managed with Mycofenolate Mofetil,
likely related with the lower rate of acute rejection. 10
Other studies consider that there is an improvement
in the quality of life of transplanted patients in the
short (0-6 months) and long term (37-120 months),
although in the intermediate term (7-36 months) the
patients experience a worsening, coming back to pre-
transplantation levels. One possible explanation is
that in the period immediately after transplantation
the patients have a feeling of liberation from dialysis
dependence, but as time goes by they have to cope
with several somatic (e.g., the side effects from medi-
cation, medical complications, etc.) and social pro-
blems (e.g., return to work, social life, etc.) that may
explain the quality of life worsening experienced by
the patients before achieving complete adaptation to
their transplant.11
Other recently published studies show the phases
through which somebody receiving a renal transplant
must go: «alertness», «adaptation», and «exhaus-
tion», that is to say, they have more negative feelings
(anxiety and depression) and worse physical self-este-
em during the first year («alertness»), and two years
and on from transplantation («exhaustion»), with no
significant differences between these two period, but
with differences when both periods are compared
with the 13-24 months interval («adaptation»), during
which the patients improve.12 Following this line of
thought, four possible phases are proposed during the
process of adaptation to renal transplant: 1) «begin-
ning», which is characterized by a fear to the unk-
nown and the search for physical indicators of well-
being or discomfort; 2) «awareness», a time during
which the patient becomes familiar with the new
physical feelings and care, and usually he/she starts
thinking about his/her limitations, risks, and capabili-
ties; 3) «thinking», during which he patient goes th-
rough an unstable period, with elaboration of new
values and believes about the disease; and 4) «re-
adaptation», during which the patient will resolve the
doubts to which he/she was confronted in the past
(e.g., «what can I do, or cannot do?,» «What is my
role within the family?», «What is my role within the
social group?», etc.).13
From all these studies, we may conclude that after
renal transplant, the patient’s HRQOL is not stabili-
zed but different phases are experienced, ones better
and other worse. All of this will depend on the time
periods being compared, which vary in the different
investigations. Given he importance of this issue, the
main objective of our investigation was to analyze the
evolution of HRQOL in renal transplant patients, con-
sidering four different periods: the pre-transplantation
phase (the time at which the patient is included in
transplant waiting list), and three post-transplantation




We selected all patients consecutively receiving
their first dead-donor renal transplant at the Virgen
del Rocío University Hospital of Seville, during he
period October of 2003 and June of 2006.
Procedure
Renal transplant patients were assessed at four dif-
ferent phases: at the time of inclusion in the renal
transplant waiting list, and at three, six, and twelve
months from receiving the graft. 
In the first place, when patients were on the wai-
ting list, and after offering them information about
the study and resolve all of their doubts, they gave
their written informed consent, taking into account
that their participation was voluntary and that they
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could withdraw from the study whenever they wan-
ted, without giving any explanation and without any
repercussion on their medical care. In the second
place, by means of a structured interview, we gathe-
red several demographic and clinical data, which
were updated at every study phase. Thirdly, at each
study phase we assessed HRQOL by means of three
questionnaires. 
Four inclusion criteria were required among the
general characteristics for selecting the subjects: 1)
age 18 years and older; 2) sufficient cognitive capa-
city to fill out the questionnaires, that is to say, they
should not have any impairment of their sensorial
aptitudes or mental state preventing them from
being oriented in space and time or maintain a con-
gruent conversation; 3) being included in the renal
transplant waiting list; and 4) giving their written in-
formed consent to participate into the study. On the
other hand, in order to be able to give answer to the
objective planned, we only included those patients
that had filled out all the questionnaires at the four
investigation phases.
Instruments
Structured interview, compounded by three sets of
information: 1) general data: gender, age, height,
etc., 2) demographical data: income level, educatio-
nal level, working status, etc., and 3) clinical data:
these were asked to the physician in charge of the
patient and referred to different areas such as gene-
ral personal history (cigarette and alcohol consump-
tion, arterial hypertension, dyslipidemia, diabetes,
and COPD), main diagnosis (vascular, diabetes, glo-
merulonephritis, interstitial, polycystic renal disea-
se, and others), data of inclusion in the waiting list,
time on renal replacement therapy, date of trans-
plantation and number of transplants, initial graft
dysfunction, laboratory data (hemoglobin, serum
creatinine, albumin, etc.), type of immunosuppressi-
ve therapy for the transplant (cyclosporin, azathio-
prine, sirolimus, etc.), and number of hospital ad-
missions, and their duration. Some clinical data
were directly obtained at the first study phase (wai-
ting list) and others during the protocoled follow-up
of the patients (at three, six, and twelve months from
receiving the graft).
SF-36 Health Questionnaire: we used the Spanish
version (validated by J. Alonso and L. Prieto14) of the
original «SF-36 Health Survey» developed by Ware
and Sherbourne.15 It comprised 36 items, with several
answering options each, which are grouped in eight
domains: «physical functioning», «role limitations
due to physical problems», «body pain», «general he-
alth», «vitality», «social functioning», «role limita-
tions due to emotional problems», and «mental he-
alth». A score is obtained at each domain, varying
from 0 (the worst health status) to 100 (the best health
status). The scores of these domains are grouped in a
physical compounded score (PCS) and mental com-
pounded score (MCS).
EuroQOL 5-D (EQ): we used the Spanish version
(validated by M. Rué and X. Badía16) of the original
«EuroQOL» questionnaire.17 It comprises a descripti-
ve system of the health status with five domains: «mo-
bility», «self care», «daily living activities», «pain/dis-
comfort», and «anxiety/depression». Each one of
them comprises three items defining three severity le-
vels: from 1 (the best quality of life) to 3 (the worst
quality of life). Besides, it includes a self-evaluation of
the health state or analogue visual scale, ranging from
1 (the worst possible health status) to 100 (the best
possible health status).
End-Stage Renal Disease Symptom Checklist-Trans-
plantation Module (ESRD-SCL)18: this questionnaire is
in its validation phase in a multicenter prospective
study within the Thematic Transplantation Investiga-
tion Network. It comprises 43 items scored following
a Likert-like scale ranging from 0 (complete absence
of the symptom) to 4 (very present symptom). These
items are grouped in six domains assessing HRQOL
in renal transplant recipients, and taking into account
the effects of immunosuppressive therapy: «limita-
tions in the physical capacity», «limitations in the
cognitive capacity», «cardiac and renal dysfunction»,
«side effects from corticosteroids», «increased hair
growth», and «transplant-associated psychological
disorders». A score is obtained for each domain ran-
ging from 0 (best HRQOL) to 4 (worst HRQOL).
RESULTS
We selected a group of 28 patients (15 men and
13 women, with mean age of 40.61 years) that con-
secutively received their first dead-donor renal
transplant at the de Virgen del Rocío University Hos-
pital of Seville. Eighty-two point one percent of
them had a personal history of arterial hypertension
and the cause of their renal disease was: glomerulo-
nephritis (56.5%), polycystic renal disease (13.1%),
interstitial nephropathy (8.7%), diabetes mellitus
(4.3%), and other causes (17.4%). The average time
on dialysis was 28.41 months and the average time
on the transplant waiting list was 19.71 months. The
mean serum creatinine value before transplantation
was 8.12, decreasing to 1.76, 1.69, and 1.62 at
three, six, and twelve months from transplantation,
respectively.
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In order to analyze the evolution of HRQOL in
renal transplanted patients, we carried out a compari-
son of the different domains assessed by the question-
naires used in this study at four different moments: at
the time of patient inclusion in the renal transplant
waiting list, and at three, six, and twelve months from
receiving the renal graft. We firstly applied a variance
analysis for repeated measurements, and secondly,
for those domains being significant and in order to
know at what temporal moments the differences oc-
curred, we carried out post-hoc comparisons (paired
comparisons between the levels of the time factor).
We also adjusted by the Bonferroni’s correction in
order to control the error rate for both the critical le-
vels and the confidence intervals.
As shown in Tables I, II and III, by comparing the
different phases of this study, eight domains were
statistically significant: «physical functioning» (p <
0.01), «role limitations due to physical problems»
(p < 0.01), «vitality» (p < 0.05), «mental health» (p
< 0.05), «daily living activities» (p < 0.01), «current
health» (p < 0.01), «cardiac and renal dysfunction»
(p < 0.01) and «side effects from corticosteroids» (p
< 0.01). For all the domains but the last one, it is ob-
served that one year after transplantation the patients
experience a improvement as compared with the
phase they remained on the waiting list. 
For SF-36, when the pre-transplantation phase is
compared with the time «six months after transplan-
tation», we observed a significant improvement in
this latter phase for the domains «vitality» (p < 0.01)
and «mental health» (p < 0.05). This same trend is
observed for the variable «physical functioning» (p
< 0.05) when the phases three- and six-months post-
transplantation are compared, and in the variables
«physical functioning» (p < 0.01) and «role limita-
tions due to physical problems» (p < 0.01), when
the phases three- and twelve-months post-transplan-
tation are compared (table I). About the EuroQol 5-
D (EQ), we should point out that there is a signifi-
cant improvement during the last phase in the
variable «daily living activities» (p < 0.01) when the
phases three- and twelve-months post-transplanta-
tion are compared. This same evolution was obser-
ved for the domain «current health» when the pre-
transplantation phase is compared with the three-
and six-months post-transplantation phases (p <
0.05 and p < 0.01, respectively), the patients signifi-
cantly improving in the two last temporal moments
(table II). On the other hand, for the ESRD-SCL, the
domain «cardiac and renal dysfunction» improves
in the long term, mainly when the pre-transplanta-
tion phase is compared with the three post-trans-
plantation phases (three- (p < 0.01), six- (p < 0.01),
and twelve-months (p < 0.01)). Completely the op-
posite is observed with the variable «side effects
from corticosteroids», in which we observe a worse-
ning expressed by the patients as time goes by, espe-
cially when the pre-transplantation phase is compa-
red with the three post-transplantation phases
(three- (p < 0.01), six- (p < 0.01), and twelve-months
(p < 0.01)) (table III).
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Table I. Progression of HRQOL (SF-36) in renal transplanted patients
Pre-transplantation Post-transplantation phase Comparison between phases
SF-36 phase 3 months 6 months 12 months Sig. Pre-3 Pre-6 Pre-12 3-6 3-12 6-12
(n = 28) (n = 28) (n = 28) (n = 28) months months months months months months 
Physical functioning 78.92 67.67 80.00 85.71 0.001** 0.112 1.000 0.613 0.012* 0.000** 0.249
Role limitations due to 37.32 39.64 55.00 58.92 0.006** 1.000 0.685 0.234 0.195 0.005** 1.000
physical problems
Body pain 83.03 80.71 88.12 82.23 0.684 – – – – – –
General health 35.89 45.17 45.71 47.14 0.167 – – – – – –
Vitality 52.85 65.89 73.03 66.78 0.017* 0.313 0.008** 0.081 1.000 1.000 1.000
Social functioning 68.75 70.98 81.25 81.25 0.114 – – – – – –
Role limitations due 65.47 75.83 69.53 69.05 0.779 – – – – – –
to emotional problems
Mental health 66.71 76.92 80.10 77.14 0.028* 0.209 0.021* 0.122 1.000 1.000 1.000
Note: The scores range 0-100. The higher the score the better the HRQOL, *p < 0.05, **p < 0.01.
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DISCUSSION
After having analyzed the results, we found that
renal transplant patients experience significant
changes during the transplantation process, essen-
tially in four different sets: 1) physical: «physical
functioning», «side effects from corticosteroids»,
and «cardiac and renal dysfunction»; 2) psychologi-
cal: «vitality» and «mental health»; 3) performance
of daily living activities: «role limitations due to
physical problems» and «daily living activities»; and
4) subjective perception of the health status: «cu-
rrent health.»
In all of these areas (but the variable «side effects
from corticosteroids») the patients improve in the
long-term when comparing the pre-transplantation
phase (when the patients are on the waiting list) to the
post-transplantation phase (within one year of recei-
ving the graft). The reasons explaining why the
HRQOL is worse during the phase on the waiting list
include not only physical deterioration and emotional
weariness due to hemodialysis, but also the feeling of
loss of freedom since the patients have to be reacha-
ble 24 hours a day, the fact that it is impossible for
them to estimate the time they are going to wait until
being transplanted, and the high anxiety level genera-
ted by the thought of having to go into the operating
room and being submitted to a high-risk surgical in-
tervention. If we add to all these reasons the fact that
after receiving the graft they will not depend on dialy-
sis, which obliges them to commute to the hospital
three or more days in the week, and they have more
time to return to their daily living activities (e.g.,
work, studies, attention to their families, etc.), with no
doubt all this has a positive impact on their physical,
psychological, and social well-being in the long-
term.19
In the physical domain we observe a renal trans-
plant-related improvement with time in «cardiac and
renal dysfunction», mainly due to the disappearance
of the negative effects of being on dialysis and of the
renal disease itself (e.g., palpitations from high blood
pressure, swollen feet, tingling on the legs, tendency
for bruises, and severe thirst), but the «physical func-
tioning» of the patients experiences a significant de-
crease at three months from transplantation, that is to
say, just at that time the patients’ health limits them to
carry out vigorous efforts (such as running, lifting
heavy objects, participating in strenuous sports) or
moderate efforts (moving a table, vacuum cleaning,
play bowling, walking for more than one hour), as
well as carrying the grocery bags, climbing up the
stairs, squeaking or kneeing, doing own self-care, etc.
One possible explanation is that patients overdo ad-
hering to therapeutic prescriptions, that is to say, take
care of themselves in excess because they fear to do
efforts that may damage their kidney and loose their
graft. Besides, sometimes the patients have extremely
optimistic expectancies with regards to transplanta-
tion (they expect not to have any medical or psycho-
logical complication) that immediately after receiving
the transplant are not reached, especially if we take
into account the «side effects from corticosteroids»
(for instance, the worry about the physical look, the
swollen face, the susceptibility for infections, the fa-
cial changes, etc.) that patients undergo after trans-
plantation and that they perceive as very disturbing,
even limiting the improvement derived from trans-
plantation and altering their body image.20, 21 Within
this context, we should take into account that trans-
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Table II. Progression of HRQOL (EUROQOL-5D) in renal transplant patients
Pre-transplantation Post-transplantation phase Comparisons between phases
EUROQOL-5D phase 3 months 6 months 12 months Sig. Pre-3 Pre-6 Pre-12 3-6 3-12 6-12
(n = 28) (n = 28) (n = 28) (n = 28) months months months months months months 
Mobility 1.00 1.07 1.00 1.04 0.382 – – – – – –
Self care 1.04 1.04 1.04 1.00 0.409 – – – – – –
Daily living activities 1.29 1.61 1.29 1.11 0.000** 0.103 1.000 0.576 0.103 0.000** 0.576
Pain/discomfort 1.43 1.32 1.39 1.36 0.838 – – – – – –
Anxiety/depression 1.32 1.21 1.21 1.36 0.503 – – – – – –
Current health 60.57 75.71 74.11 72.14 0.008** 0.020* 0.009** 0.103 1.000 1.000 1.000
Note: For the first five domains, which scores range 1-3, the higher the score the worse the HRQOL. For the last domain, which scores ranges 0-100, e higher the score the bet-
ter the HRQOL, *p < 0.05, **p < 0.01.
Document downloaded from http://www.elsevier.es, day 06/06/2017. This copy is for personal use. Any transmission of this document by any media or format is strictly prohibited.
planted patients usually receive a lot of information
about the surgical procedure and pre-surgical prepa-
ration, but little information regarding the negative ef-
fects from transplant, including the adverse effects
from immunosuppressive therapy.22
This close relationship with the physical area lies in
the domain of doing the daily living activities, in
which we have included, on the one hand, the do-
main referring to «daily living activities» and, on the
other hand, the domain «role limitations due to phy-
sical problems». In the first domain, we observed that
patients improve in the long run, but at three months
there is a significant decrease; comparing the four
phases, it is in that phase during which the patients
experience more problems to carry out their daily li-
ving activities, such as work, study, doing housekee-
ping, family activities, or other kind of activities du-
ring their spare time. Similarly, during the second
phase, although there is a progressive improvement
in these domains as time goes by, the most significant
difference is observed when the periods three- and
twelve-months post-transplantation are compared,
the patients being significantly worse at three months
since because of their physical health they have to re-
duce the time spent or doing more difficultly work-re-
lated tasks or daily living activities, or not doing them
at all. The factors implicated may be, in the first
place, the high frequency at which the patients must
go to the hospital after transplantation to do check-
outs (once or twice a week), and in the second place,
the fear to have infections since their immune system
is depressed by immunosuppressants and they avoid
going out to crowded places because they fear getting
sick; thus, their personal health care exceeds that
prescribed by their doctor; finally, the fact that some-
times they have to get integrated in a social and wor-
king environment that many times is not the best con-
sidering their physical conditions.12, 23
About the psychological domain, several studies
highlight that the changes transplanted patients un-
dergo (e.g., anxiety, depression, fantasies about the
donor, dissatisfaction with body image, sexual disor-
ders, guilt feelings because of the donor’s death, etc.)
are the single most important cause influencing the
HRQOL after a successful transplantation.24, 25 In our
study, we have particularly included two domains
within the psychological area («vitality» and «mental
health»), and we observed the same progression in
both of them: in the long-term, the patients improve
considerably, with the most remarkable differences
being observed between the pre-transplantation
phase and the period of 6 months post-transplanta-
tion. After the transplant, the patients particularly ex-
perience a high energy level that is expressed as the
feeling of being full of life and with no exhaustion or
tiredness («vitality»). Besides, they feel less and less
nervous, calmer and quieter, with less discourage-
ment and depression, overall more happy («mental
health»). With no doubt, making the acquaintance of
other people in the same situation, after the trans-
plant, either through associations or at the hospital it-
self, contributes to this and relieves the patients since
they talk about emergent problems and how to cope
with them, which diminishes the patient’s uncertain-
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Table III. Progression of HRQOL (ESRD-SCL) in renal transplant patients
Pre-transplantation Post-transplantation phase Comparisons between phases
ESRD-SCL phase 3 months 6 months 12 months Sig. Pre-3 Pre-6 Pre-12 3-6 3-12 6-12
(n = 28) (n = 28) (n = 28) (n = 28) months months months months months months 
Limitations in the 0.75 0.73 0.63 0.65 0.563 – – – – – –
physicial capacity
Limitations of the 0.61 0.70 0.57 0.75 0.135 – – – – – –
cognitive capacity
Cardiac and renal dysfunction 1.09 0.37 0.35 0.33 0.000** 0.000** 0.000** 0.000** 1.000 1.000 1.000
Side effects 0.57 1.67 1.72 1.41 0.000** 0.000** 0.000** 0.000** 1.000 1.000 0.226
from corticosteroids
Increased 0.16 0.28 0.22 0.27 0.475 – – – – – –
hair growth
Transplant-associated 0.94 1.05 0.90 0.98 0.626 – – – – – –
psychological disorders
Note: The scores range 0-4. The higher the score, the worse the HRQOL, **p < 0.01.
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ties before the unknown. Moreover, all the disturbing
feelings and emotions that the patients had while they
were on the waiting list vanish; among others, we
should point out anger («why this occurred precisely
to me?»), anxiety («for how long will I live if there is
no donor?»), and guilt («if I were lived in another
way», «If I had better taken care of myself»).26 This
positive progression is reflected in the subjective per-
ception that the patients have about their own health
status («current health»), which experiences a long-
term improvement, the most remarkable differences
being observed between the pre- and post-transplan-
tation phases (at three and sic months); the current
health status at these two latter moments is fairly
good, and remains stable thereafter. 
As conclusions, in all the dimensions that were sig-
nificant (but in the variable «side effects from corti-
costeroids»), the patients experience an improvement
after the transplant when the pre- and post-transplan-
tation phases are compared. In general terms, in this
latter phase, there is a progressive improvement as
time goes by (three, six and twelve months), reaching
a point at which HRQOL stabilizes in most of the do-
mains. That is to say, in the long term, the patients get
adapted to all the circumstances derived from the
transplant: they get used to the prescriptions, the get
integrated in their social and working environment,
they no longer fear organ rejection, and they find
more support from their families since this one is also
more psychologically recovered from the emotional
impact imposed by the transplant (for example, fear
to patient’s death, worry about whether the graft
works or not, etc.).27
Finally, we should highlight that although as time
goes by HRQOL in transplanted patients improves,
therapeutic intervention programs should meet the
psychological demands posed by these patients du-
ring the transplantation process in order to help them
at any time to adaptively cope with this situation, in
both the patients and their relatives. 
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